论文部分内容阅读
目的:探讨谷维素联合β受体阻滞剂对心血管神经症的临床治疗效果。方法:选取心血管神经症患者141例,将其随机分为两组,其中,对照组68例,观察组73例,使其有可比性。对照组患者给予常规治疗;观察组患者在对照组基础上给予谷维素联合β-受体阻滞剂治疗。对两组患者的心血管神经症评分情况以及治疗效果进行评价和比较。结果:观察组患者在治疗1周、2周、4周及6周时,心血管神经症积分均明显低于对照组;于治疗2周时临床疗效明显优于对照组。上述比较两组差异明显,有统计学意义(P<0.05)。结论:对心血管神经症患者实施谷维素联合β受体阻滞剂治疗,具有较为确切的临床效果。
Objective: To investigate the clinical effect of oryzanol combined with β-blocker on cardiovascular neurosis. Methods: A total of 141 patients with cardiovascular neurosis were selected and randomly divided into two groups. Among them, 68 patients in the control group and 73 patients in the observation group were comparable. Patients in the control group were given routine treatment. Patients in the observation group were given oryzanol combined with β-blockers on the basis of the control group. Evaluation and comparison of cardiovascular neurosis score and treatment effect of two groups of patients. Results: The scores of cardiovascular neurosis in observation group were significantly lower than those in control group at 1 week, 2 weeks, 4 weeks and 6 weeks after treatment. The clinical curative effect in observation group was better than that of control group at 2 weeks. The above two groups were significantly different, with statistical significance (P <0.05). Conclusion: The treatment of patients with cardiovascular neurosis with oryzanol combined with β-blockers, has a more exact clinical effect.